Protagonist Therapeutics (PTGX) Non-Current Deffered Revenue (2017 - 2025)
Protagonist Therapeutics (PTGX) posted Non-Current Deffered Revenue of $2.8 million for Q3 2025, down 48.13% sequentially from $5.4 million in Q2 2025, and down 83.11% YoY from $16.5 million in Q3 2024.
Powered by 
Analysis
Protagonist Therapeutics (PTGX) Non-Current Deffered Revenue (2017 - 2025) Analysis & Trends
Protagonist Therapeutics has reported Non-Current Deffered Revenue for 6 years, with the latest figure at $2.8 million in Q3 2025.
- Quarterly Non-Current Deffered Revenue fell 83.11% year-over-year to $2.8 million in Q3 2025, while the trailing twelve-month figure through Sep 2025 was $2.8 million (down 83.11% YoY) and the FY2024 annual result came in at $11.7 million, changed N/A from the prior year.
- Non-Current Deffered Revenue eased to $2.8 million in Q3 2025 per PTGX's latest filing, from $5.4 million in the prior quarter.
- Over five years, Non-Current Deffered Revenue peaked at $28.9 million in Q1 2024 and troughed at $2.8 million in Q3 2025.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Non-Current Deffered Revenue (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 138.47 Bn | 130.62 Bn | 2.84 Bn | - |
| 2 | Regeneron Pharmaceuticals | 85.18 Bn | 77.19 Bn | 3.93 Bn | 220.40 Mn |
| 3 | Argenx Se | 63.38 Bn | 58.19 Bn | 1.37 Bn | - |
| 4 | Moderna | 58.09 Bn | 52.95 Bn | 52.00 Mn | 147.00 Mn |
| 5 | Revolution Medicines | 44.33 Bn | 44.33 Bn | - | - |
| 6 | BeOne Medicines | 40.02 Bn | 34.92 Bn | 1.53 Bn | - |
| 7 | Alnylam Pharmaceuticals | 35.57 Bn | 32.27 Bn | 992.69 Mn | - |
| 8 | Royalty Pharma | 28.45 Bn | 27.61 Bn | - | - |
| 9 | Insmed | 27.48 Bn | 26.32 Bn | 358.27 Mn | - |
| 10 | Protagonist Therapeutics | 9.61 Bn | 9.61 Bn | - | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Sep 30, 2025 | 2.79 Mn |
| Jun 30, 2025 | 5.38 Mn |
| Mar 31, 2025 | 8.18 Mn |
| Dec 31, 2024 | 11.68 Mn |
| Sep 30, 2024 | 16.51 Mn |
| Jun 30, 2024 | 20.76 Mn |
| Mar 31, 2024 | 28.92 Mn |
| Sep 30, 2020 | 4.11 Mn |
| Jun 30, 2020 | 16.78 Mn |
| Mar 31, 2020 | 20.42 Mn |
| Dec 31, 2019 | 23.79 Mn |
| Sep 30, 2019 | 22.20 Mn |
| Jun 30, 2019 | 23.85 Mn |
| Dec 31, 2018 | 799,000.00 |
| Sep 30, 2018 | 797,000.00 |
| Jun 30, 2018 | 793,000.00 |
| Mar 31, 2018 | 694,000.00 |
| Dec 31, 2017 | 547,000.00 |
| Sep 30, 2017 | 332,000.00 |
| Jun 30, 2017 | 83,000.00 |